Back
AeroVironment 10K Form
Sell
40
AVAV
AeroVironment
Last Price:
$125.06
Seasonality Move:
6.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-03-05 | 10Q | AVAV/AeroVironment Quarterly |
2023-12-06 | 10Q | AVAV/AeroVironment Quarterly |
2023-09-06 | 10Q | AVAV/AeroVironment Quarterly |
2023-08-18 | 10K | AVAV/AeroVironment Annual |
2023-06-28 | 10K | AVAV/AeroVironment Annual |
2023-03-06 | 10Q | AVAV/AeroVironment Quarterly |
Receive AVAV News And Ratings
See the #1 stock for the next 7 days that we like better than AVAV
AVAV Financial Statistics
Sales & Book Value
Annual Sales: | $716.7M |
---|---|
Cash Flow: | $-29.6M |
Price / Cash Flow: | 94.57 |
Annual Sales: | $30.51 |
Price / Book: | 4.1 |
Profitability
EPS (TTM): | 1.18000 |
---|---|
Net Income (TTM): | $33M |
Gross Margin: | $283.9M |
Return on Equity: | 3.93% |
Return on Assets: | 3.26% |
AeroVironment Earnings Forecast
Key AeroVironment Financial Ratios
-
The Gross Profit Margin over the past 20 years for AVAV is 39.62%.
-
The Selling, General & Administrative Expenses for AVAV have been equal to 15.96% of Gross Profit Margin.
-
The Research & Development expenses have been 13.63% of Revenue.
-
The Interest Expense is 7.07% of Operating Income.
-
The Net Earning history of AVAV is 8.32% of Total Revenues.
-
Per Share Earnings over the last 22 years have been positive in 11 years.
AeroVironment Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Aerospace & Defense |
Sector: | Industrials |
Current Symbol: | AVAV |
CUSIP: | 008073 |
Website: | avinc.com |
Debt
Debt-to-Equity Ratio: | 0.03 |
---|---|
Current Ratio: | 4.22 |
Quick Ratio: | 2.89 |
Price-to-Earnings
Trailing P/E Ratio: | 57.34 |
---|---|
Forward P/E Ratio: | 29.67 |
AVAV Technical Analysis vs Fundamental Analysis
Sell
40
AeroVironment (AVAV)
is a Sell
Is AeroVironment a Buy or a Sell?
-
AeroVironment stock is rated a SellThe current AeroVironment [AVAV] share price is $125.01. The Score for AVAV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.